Health
Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy – News-Medical.Net
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas….
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas. Many patients have strong responses to CAR T; however, some have only a short response and develop disease progression quickly. Unfortunately, it is not completely understood why these patients have progression. In an article published in Proceedings of the Royal Society B, Moffitt Cancer Center researchers use mathematical modeling…
-
Noosa News16 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General22 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
General17 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News18 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate